ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $161,534,000 | +16349.5% | 3,486,602 | +8559.8% | 1.41% | +13980.0% |
| Q1 2019 | $982,000 | +451.7% | 40,262 | +244.1% | 0.01% | +900.0% |
| Q3 2018 | $178,000 | -95.6% | 11,700 | -95.1% | 0.00% | -96.3% |
| Q2 2018 | $4,046,000 | -1.1% | 241,106 | -3.8% | 0.03% | -3.6% |
| Q1 2018 | $4,092,000 | +83.0% | 250,727 | -6.1% | 0.03% | +100.0% |
| Q2 2017 | $2,236,000 | +8.4% | 267,103 | +15.8% | 0.01% | -17.6% |
| Q1 2017 | $2,062,000 | +1105.8% | 230,700 | +298.1% | 0.02% | +750.0% |
| Q1 2016 | $171,000 | -79.7% | 57,950 | -71.0% | 0.00% | -75.0% |
| Q4 2015 | $843,000 | +569.0% | 199,800 | +623.9% | 0.01% | +700.0% |
| Q3 2015 | $126,000 | -64.4% | 27,600 | -43.7% | 0.00% | -75.0% |
| Q2 2015 | $354,000 | -66.7% | 49,053 | -66.0% | 0.00% | -60.0% |
| Q1 2015 | $1,062,000 | +1179.5% | 144,150 | +768.4% | 0.01% | +400.0% |
| Q4 2013 | $83,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |